Clincosm LogoSign in Get a demo

Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections

Sponsor
Institute of Progressive Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT00642785
Collaborator
(none)
500
Enrollment
3
Duration (Months)

Study Details

Study Description

Brief Summary

The research question to be addressed is whether indirect phototherapy based activation of the body's alternative cellular energy (ACE) pathway will lead to expedited healing of active herpes simplex virus (HSV) and herpes zoster virus (HZV)skin lesions, and also possibly inhibit both latent HSV infections and residual HZV infections.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    500 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    A Research Study Examining the Effectiveness of Distant Activation of ACE Pigments Associated With Recurrent Human Herpes Simplex Virus-Induced Skin Lesions.
    Study Start Date :
    Jan 1, 2008
    Actual Primary Completion Date :
    Apr 1, 2008
    Actual Study Completion Date :
    Apr 1, 2008

    Arms and Interventions

    Arm Intervention/Treatment
    1

    Patients with active oral or genital HSV skin lesions
    2

    Patients with a history of recurrent oral or genital HSV but without an active lesion at the time of treatment
    3

    Patients with active shingles/zoster
    4

    Patients with post herpetic neuralgia

    Outcome Measures

    Primary Outcome Measures

    1. Expedited healing of active lesions [Within 1 day following therapy]

    Secondary Outcome Measures

    1. Recurrence of lesions and/or symptoms [3 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Clinical diagnosis of active, latent or residual HSV or HZV infection
    Exclusion Criteria:
    • Unwilling or unable to provide Informed Consent

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Institute of Progressive Medicine

    Investigators

    • Principal Investigator: W John Martin, MD, PhD, Institute of Progressive Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00642785
    Other Study ID Numbers:
    • 071/081
    First Posted:
    Mar 25, 2008
    Last Update Posted:
    Jun 3, 2008
    Last Verified:
    May 1, 2008
    Keywords provided by , ,
    herpes
    HSV
    zoster
    HZV
    shingles
    Additional relevant MeSH terms:
    Herpes Zoster
    Herpes Simplex

    Study Results

    No Results Posted as of Jun 3, 2008